Percutaneous Septal Ablation for Hypertrophic Cardiomyopathy and Mid-ventricular Obstruction | Zendy

Hubert Seggewiß | Zendy; Laura M. Faber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Percutaneous Septal Ablation for Hypertrophic Cardiomyopathy and Mid-ventricular Obstruction

Author(s) -

Hubert Seggewiß,

Laura M. Faber

Publication year - 2000

Publication title -

european journal of echocardiography

Language(s) - English

Resource type - Journals

eISSN - 1525-2167

pISSN - 1532-2114

DOI - 10.1053/euje.2000.0032

Subject(s) - medicine , cardiology , alcohol septal ablation , hypertrophic cardiomyopathy , percutaneous , asymptomatic , diastole , ablation , ventricular outflow tract obstruction , cardiomyopathy , occlusion , blood pressure , heart failure , obstructive cardiomyopathy

Percutaneous transluminal septal myocardial ablation by alcohol-induced septal branch occlusion is a new treatment option in symptomatic patients with hypertrophic cardiomyopathy and subaortic, SAM-associated obstruction. We report on a patient with mid-ventricular obstruction and echocardiographic-guided reduction of septal hypertrophy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research